CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −100 | $144.52 | $14K | 61,643 |
| 2024-06-14 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,625 | 130,750 | ||
| 2024-06-05 | Ranganath Anil P. See remarks | Sale | −703 | $135.21 | $95K | 8,809 |
| 2024-06-05 | Basile Edward M Director | Sale | −1,193 | $138.08 | $165K | 732 |
| 2024-06-03 | Gordon Stephen Chief Financial Officer | Option exercise 10b5-1 | +2,060 | $38.46 | $79K | 23,359 |
| 2024-06-03 | Gordon Stephen Chief Financial Officer | Sale 10b5-1 | −2,060 | $135.93 | $280K | 21,299 |
| 2024-06-03 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,060 | 15,417 | ||
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,459 | $38.46 | $56K | 22,302 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +417 | $66.10 | $28K | 22,719 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,084 | $13.28 | $14K | 23,803 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −105 | $129.92 | $14K | 23,698 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −219 | $130.79 | $29K | 23,479 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −539 | $131.87 | $71K | 22,940 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −921 | $132.71 | $122K | 22,019 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −567 | $133.67 | $76K | 21,452 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −152 | $134.66 | $20K | 21,300 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −457 | $135.97 | $62K | 20,843 |
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,459 | 13,125 | ||
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −417 | 13,766 | ||
| 2024-06-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,084 | 22,750 |
Page 12 of 20 · 390 trades